Stephanie Downs‐Canner

1.6k total citations · 1 hit paper
57 papers, 1.1k citations indexed

About

Stephanie Downs‐Canner is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Stephanie Downs‐Canner has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 30 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Stephanie Downs‐Canner's work include Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Stephanie Downs‐Canner is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Stephanie Downs‐Canner collaborates with scholars based in United States, Canada and South Korea. Stephanie Downs‐Canner's co-authors include Jonathan S. Serody, Benjamin G. Vincent, Jeremy A. Meier, David L. Bartlett, Peter H. Shaw, Herbert J. Zeh, Nataša Obermajer, Mark E. O’Malley, Heather Jones and Kunle Odunsi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Stephanie Downs‐Canner

44 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B Cell Function in the Tumor Microenvironment

2022 193 citations Stephanie Downs‐Canner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie Downs‐Canner United States	17	545	278	247	231	212	57	1.1k
Amel Mézlini Tunisia	18	421 0.8×	290 1.0×	214 0.9×	65 0.3×	195 0.9×	125	1.0k
Jiří Špaček Czechia	15	526 1.0×	122 0.4×	109 0.4×	117 0.5×	359 1.7×	59	1.1k
Ann K. Folkins United States	19	225 0.4×	150 0.5×	137 0.6×	147 0.6×	193 0.9×	54	1.3k
Jurgen M.J. Piek Netherlands	18	269 0.5×	99 0.4×	218 0.9×	311 1.3×	286 1.3×	93	1.6k
Michael Conner United States	23	521 1.0×	267 1.0×	236 1.0×	124 0.5×	489 2.3×	72	1.9k
Shane Zaidi United Kingdom	23	660 1.2×	156 0.6×	75 0.3×	314 1.4×	306 1.4×	61	1.3k
Susan Miesfeldt United States	17	564 1.0×	189 0.7×	242 1.0×	498 2.2×	343 1.6×	48	1.6k
Solveig Tingulstad Norway	20	294 0.5×	236 0.8×	164 0.7×	111 0.5×	263 1.2×	39	1.9k
Sveinung Wergeland Sørbye Norway	23	437 0.8×	251 0.9×	236 1.0×	144 0.6×	403 1.9×	70	1.4k
Elizabeth Feldman United States	16	245 0.4×	180 0.6×	248 1.0×	65 0.3×	175 0.8×	30	995

Countries citing papers authored by Stephanie Downs‐Canner

Since Specialization

Citations

This map shows the geographic impact of Stephanie Downs‐Canner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Downs‐Canner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Downs‐Canner more than expected).

Fields of papers citing papers by Stephanie Downs‐Canner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Downs‐Canner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Downs‐Canner. The network helps show where Stephanie Downs‐Canner may publish in the future.

Co-authorship network of co-authors of Stephanie Downs‐Canner

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Downs‐Canner. A scholar is included among the top collaborators of Stephanie Downs‐Canner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Downs‐Canner. Stephanie Downs‐Canner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Youngjun, et al.. (2025). IL-21 shapes the B cell response in a context-dependent manner. Cell Reports. 44(1). 115190–115190. 6 indexed citations

Flanagan, Meghan R., Stephanie Downs‐Canner, Samantha M. Thomas, et al.. (2025). A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer. Annals of Surgical Oncology. 32(8). 5551–5562.

Abuhadra, Nour, Fresia Pareja, Hannah Y. Wen, et al.. (2025). Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer. npj Breast Cancer. 11(1). 110–110.

Farahani, Sahar J., Varadan Sevilimedu, Edi Brogi, et al.. (2025). Nipple Discharge and Pathologic Involvement of the Nipple-Areolar Complex: Reconsidering Guidelines for Nipple-Sparing Mastectomy. Annals of Surgical Oncology. 32(11). 8434–8444.

Myers, Sara P., Sherry Shen, Stephanie Downs‐Canner, et al.. (2024). Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer. npj Breast Cancer. 10(1). 39–39. 6 indexed citations

Myers, Sara P., Nour Abuhadra, Giacomo Montagna, et al.. (2023). Impact of neoadjuvant chemo-immunotherapy on surgical outcomes and time to radiation in triple negative breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 555–555.

Kapadia, Muneera R., et al.. (2023). Analysis of Specimen Mammography with Artificial Intelligence to Predict Margin Status. Annals of Surgical Oncology. 30(12). 7107–7115. 6 indexed citations

Roberson, Mya L., Philip M. Spanheimer, Kristalyn K. Gallagher, et al.. (2022). The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment. npj Breast Cancer. 8(1). 27–27. 16 indexed citations

Strassle, Paula D., Katherine E. Reeder‐Hayes, Kristalyn K. Gallagher, et al.. (2022). Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer. Annals of Surgical Oncology. 29(5). 3051–3061. 5 indexed citations

10.

Park, Jihye, et al.. (2022). Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2− Breast Cancer. Annals of Surgical Oncology. 29(12). 7662–7669. 6 indexed citations

11.

Reitz, Katherine M., Lauren Terhorst, Clair Smith, et al.. (2021). Healthcare providers’ perceived support from their organization is associated with lower burnout and anxiety amid the COVID-19 pandemic. PLoS ONE. 16(11). e0259858–e0259858. 27 indexed citations

12.

Fried, David, Lawrence B. Marks, Gaorav P. Gupta, et al.. (2021). Dosimetric and Clinical Factors Associated With Breast Reconstruction Complications in Patients Receiving Postmastectomy Radiation. Practical Radiation Oncology. 12(3). e169–e176.

13.

Grova, Monica, Paula D. Strassle, Kristalyn K. Gallagher, et al.. (2020). The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer. Annals of Surgical Oncology. 28(4). 2182–2190. 13 indexed citations

14.

Downs‐Canner, Stephanie, et al.. (2020). Delving deeper into disparity: The impact of health literacy on the surgical care of breast cancer patients. The American Journal of Surgery. 220(4). 806–810. 9 indexed citations

15.

Tam, Vernissia, Mazen S. Zenati, Stephanie Downs‐Canner, et al.. (2018). Practical Adherence to the Step-Up Approach for Pancreatic Necrosis: An Institutional Review. JOP, journal of the pancreas. 19(6). 1 indexed citations

16.

Downs‐Canner, Stephanie, Greg M. Delgoffe, Robert P. Edwards, et al.. (2017). Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells. Nature Communications. 8(1). 14649–14649. 133 indexed citations

17.

Downs‐Canner, Stephanie, Brian A. Boone, Amer H. Zureikat, et al.. (2014). Robotic Surgery for Benign Duodenal Tumors. Journal of Gastrointestinal Surgery. 19(2). 306–312. 28 indexed citations

18.

Zeh, Herbert J., Stephanie Downs‐Canner, J. Andrea McCart, et al.. (2014). First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity. Molecular Therapy. 23(1). 202–214. 120 indexed citations

19.

Downs‐Canner, Stephanie, Srinevas K. Reddy, Jon Cardinal, et al.. (2012). Indeterminate Pulmonary Nodules Represent Lung Metastases in a Significant Portion of Patients Undergoing Liver Resection for Malignancy. Journal of Gastrointestinal Surgery. 16(12). 2256–2259. 4 indexed citations

20.

Downs‐Canner, Stephanie & Peter H. Shaw. (2009). A Comparison of Clinical Trial Enrollment Between Adolescent and Young Adult (AYA) Oncology Patients Treated at Affiliated Adult and Pediatric Oncology Centers. Journal of Pediatric Hematology/Oncology. 31(12). 927–929. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact